was successfully added to your cart.

Reassurance on the safety of COVID-19 Vaccine AstraZeneca. Benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets

By March 18, 2021July 6th, 2021arch

European Medicines Agency’s (EMA) safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people vaccinated with COVID-19 Vaccine AstraZeneca at its extraordinary meeting of 18 March 2021.

Click here to read more


InDependent Diabetes Trust